This topic contains a solution. Click here to go to the answer

Author Question: In interrupted time-series designs, A) the experiences of a single participant are manipulated ... (Read 67 times)

EY67

  • Hero Member
  • *****
  • Posts: 531
In interrupted time-series designs,
 
  A) the experiences of a single participant are manipulated and recorded.
  B) two or more groups of participants are measured several times.
  C) a single group of participants is measured several times both before and after some event or manipulation.
  D) a single group of participants is measured once at pretreatment and once at post-treatment.

Question 2

What is the term used for the design in which a single group of participants is measured several times both before and after an event or manipulation?
 
  A) single-subject design
  B) general quasi-experimental design
  C) between-subjects design
  D) interrupted time-series design



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Answer: C

Answer to Question 2

Answer: D




EY67

  • Member
  • Posts: 531
Reply 2 on: Aug 4, 2018
Thanks for the timely response, appreciate it


lkanara2

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library